Stay updated with breaking news from Pharming Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA approval and commercial launch of Joenja® (leniolisib) in the U.S. Joenja® launch off to strong start with 23 U.S. patients on paid therapy Revenues...
Pharming Group (NASDAQ:PHAR – Get Rating) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 1,600 shares, a decline of 68.6% from the April 15th total of 5,100 shares. Based on an average daily volume of 25,000 shares, the short-interest ratio is presently […]
Pharming Group (NASDAQ:PHAR – Get Rating) will release its earnings data before the market opens on Thursday, May 11th. Analysts expect Pharming Group to post earnings of ($0.01) per share for the quarter. Pharming Group (NASDAQ:PHAR – Get Rating) last issued its earnings results on Thursday, March 16th. The company reported ($0.19) earnings per share […]
MEI Pharma (NASDAQ:MEIP – Get Rating) and Pharming Group (NASDAQ:PHAR – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, analyst recommendations, risk, institutional ownership, profitability and earnings. Profitability This table compares MEI Pharma and Pharming Group’s […]
Pharming Group (NASDAQ:PHAR – Get Rating)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $10.86, but opened at $10.34. Pharming Group shares last traded at $10.34, with a volume of 758 shares trading hands. Wall Street Analyst Weigh In A number of brokerages recently weighed in on […]